We have examined the promoter sequence requirements for Ela transactivation of the human HSP70 gene by using a transient cotransfection assay. A 5' deletion study has defined a basal transcription unit extending to -74 relative to the transcription initiation site which was fully Ela responsive. Further deletion, abolishing a CCAAT element at -67, drastically reduced basal and Ela-induced expression. A linker-scanner analysis has identified four functional elements within the basal transcription unit which may interact with CTF, SPI, TFIID, and an ATF/APl-like factor. Sequences between -100 and -188 can partially compensate for mutations in these elements. No mutation specifically abolished Ela inducibility. Any reduction in absolute Ela-induced levels was accompanied by a corresponding reduction in absolute basal levels, thereby maintaining a constant relative fold induction. We conclude that Ela transactivation of the human HSP70 promoter does not require any single basal transcription element. We also examined an HSP70 promoter fragment, containing the CCAAT element at -67 and the purine-rich element at -54, out of its normal context by fusing it upstream of a transcriptionally inactive herpes simplex virus thymidine kinase deletion construct containing only the TATA box. The resulting chimeric promoter was fully Ela responsive. Mutagenesis of this promoter fusion demonstrated that the CCAAT element was essential for detectable basal and Ela-induced expression.
mediated by DNA binding tr-ans-acting factors that select the site and modulate the rate of specific initiation (for reviews, see references 20 and 41) . General transcription factors, such as TFIID, direct RNA polymerase II to the specific start site. The same types of general factors are probably required for specific initiation from most protein-coding genes. Promoter-specific factors bind to transcription elements that regulate the frequency of RNA chain initiation. One class of transcription elements, called upstream elements, is characterized by short sequences of approximately 10 base pairs (bp) that are usually located up to about 110 bp upstream from the RNA start site. These elements modulate transcription in a distance-dependent manner. The other class of transcription elements is enhancers, which are capable of modulating transcription independent of both orientation and distance. Regulation of promoter activity depends on both the number and the type of transcription elements present. The combinatorial organization of elements allows for many complex regulatory patterns with only a small number of transcription factors.
Superimposed on the regulation conferred by protein-DNA interactions are the effects of transcription factors which do not bind to DNA. A well-studied example is the 289-amino-acid adenovirus Ela protein, which has been suggested to regulate transcriptional initiation through protein-protein interactions (for a review, see reference 1). Extensive mutagenesis of adenovirus early promoters has revealed that the sequences required for the Ela-induced transcriptional levels of these genes appear to be binding sites for transcription factors that are found in the uninfected cell (3, 16, 18, 21, 22, 36, 37) . Several recent biochemical * Corresponding author. approximately 10-fold elevation in basal levels and studies have suggested that the Ela protein increases the DNA binding activity of the cellular factors E2F (18, 37) and E4F (33) , increases the proportion of a phosphorylated, more transcriptionally active TFIIIC factor (15) , and increases the transcriptional activity of TFIID (23) . This biochemical evidence supports a model in which Ela acts by increasing the activity of a number of host cell transcription factors.
The human HSP70 promoter provides an excellent system for studying the protein-DNA and protein-protein interactions that regulate transcriptional initiation. Besides the general transcription factors, many promoter-specific factors bind to the upstream elements and may mediate several forms of regulation (12, 28, 29, 48) . Acting alone or in combinations, these upstream elements confer regulation by a variety of forms of stress, such as heat shock and incubation with heavy metals or amino acid analogs, by serum, and by the action of several oncogene products, including the adenovirus Ela protein (32, (44) (45) (46) (47) . Some of the factors that bind to these upstream elements include heat shock factor (HSF), CCAAT transcription factor (CTF), SPI, AP2, and an unidentified binding activity which may be activating transcription factor (ATF) or AP1 (Fig. 1) .
In this study, we MATERIALS AND METHODS Construction of promoter mutations and transfection vector. The construction of the transfection vector containing the chloramphenicol acetyltransferase test gene (CAT) and the neomycin phosphotransferase gene (NEO) regulated by 74 bp of the human HSP70 promoter is diagrammed in Fig.  2A . The left side of Fig. 2A describes the part of the vector containing the NEO gene. The right side describes the construction of 5' and 3' deletions, internal deletions, and linker-scanning mutations in the human HSP70 promoter fused to the CAT gene.
Deletion mutations and linker-scanner (LS) mutations were constructed by using a strategy described previously (13) . The ends of the 184-bp HindIII-HpalII fragment (-188 to -4) from pAH18 (47) were filled in with the Klenow fragment of DNA polymerase I (Klenow), SphI linkers were added, and the resulting fragment was cloned into the SplIl site of pBRN/B (13) in the orientation shown to generate pzX3. The ends of the 1,974-bp HindIII-BamtiHI (partial) fragment (-188 to +1786) from pAH18 were modified similarly, and the resulting fragment was cloned into the SphIu site of pBRN/B to generate pA5. To generate a series of 3' deletions, the parent, pA3, was linearized at Still and digested with Bal 31. Following termination of exonuclease digestion by phenol extraction and ethanol precipitation, the resulting fragments were digested with Ni-lil, leaving a blunt end adjacent to an intact BgIII site. After intramolecular ligation by T4 ligase and transformation into Escherichlia coli DH1, selected clones were sequenced by using the dideoxychain termination method on double-stranded templates (14) . The 5' deletion collection was generated similarly by using pA5.
The LS series was constructed by using selected 5' and 3' deletion mutations with endpoints 10 bp apart, the length of the BgII linker. The small BglII-BantiHI fragment from the 3' deletion was gel purified and cloned into the BglII site of the corresponding 5' deletion. The resulting LS series contains LS mutations in the context of a -188 promoter. The nomenclature refers to the parental 5' and 3' deletion mutations that were recombined for its construction. LS WT was generated by purifying the 187-bp BamtiHI-SplI fragment from pA3 and cloning it into the 4,831-bp BgII-SphI (partial) fragment from pA5. The internal deletion (ID) series was constructed by combining 3' and 5' deletion mutations whose endpoints were greater than 10 bp apart. The LSP series contains the same LS mutations but in the context of the proximal sequences to -100. For cloning convenience, two modifications were made in the LS vector sequences: an EcoRI site was destroyed with Klenow, and the sequences between the HiidIlll and Spil sites were removed. HinidlIl and SphI overhanging sequences were removed by using either the polymerase or the 3' exonuclease activity of T4 DNA polymerase as needed. Distal promoter sequences were removed by digestion with SspI (-100), which leaves a blunt end; addition of Sphli linkers; and subsequent ligation to the remaining Splil site. An LSP construct (LSP -57/-47) served as the parent for the CAT-related sequences in the transfection vector. The NEO-related sequences (left side of Fig. 2A ) were constructed from pSV2NEO (38) and a 5' deletion previously generated (pA5/-74). After (26) . This fragment was generated by digesting TK LS -47/-37 with Hindlll, rendering the end blunt with Klenow, and then cutting the resulting fragment with BamouHI, which cuts within the TK LS sequence. The resulting plasmid, HSP70/TK, fuses the HSP70 promoter to the TK promoter, destroying both the BglII and BalmHI sites in the linker sequences. This plasmid was sequenced around the promoter fusion joint to confirm the junction sequence. Mutations in this promoter fusion were generated by oligonucleotide-directed in vitro mutagenesis by using the Amersham system based on a method described previously (31) . The 602-bp SplI fragment of HSP70/TK was cloned into the polylinker region of the replicative form of MP18. and single-stranded phage DNA was prepared by standard methods (27 Cell culture and transient transfection assays. HeLa cell cultures were maintained in Dulbecco modified Eagle (DME) medium with 10% calf serum (GIBCO Laboratories) at 37°C in 7.5% CO. Transfections were conducted by using the low-percent CO,-calcium phosphate method (6) . At 16 to 24 h before transfection, cells were plated out at 2.5 x 106 cells per 10-cm dish. A 1-ml CaCl,-BBS {BES [N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acidi-buffered saline}-DNA precipitate was added to each plate (6 Roeder, unpublished results). Also depicted is a purine-rich element centered at -54 which has been found to interact with nuclear proteins by the exonuclease III footprinting assay (48) . This figure exemplifies the compactness and the repetition of transcription elements and the potential complexity that may result through their combinatorial interactions.
Construction of a specialized transfection vector. To determine the functional significance of these protein-DNA interactions in vivo. we generated an extensive collection of promoter mutations and incorporated them into a specialized transfection vector. The design of this vector and the details of its construction are described in Materials and Methods and shown in Fig. 2 . The steps taken to generate the HSP-NEO and HSP-CAT constructs are depicted in Fig. 2A . Figure 2B displays the features of the specialized transfection vector. This vector contains a promoter cassette into which all of the promoter mutations were shuttled by using the unique NdelI and MstIl sites. In Fig. 2B1 The most useful feature of this vector is the HSP-NEO gene regulated by 74 bp of the human HSP70 promoter in opposing orientation to the HSP-CAT gene. The HSP-NEO gene can serve either as a positive control (this paper) or a negative control (stress induction; G. Williams and R. Mornmoto. manuscript in preparation), depending on the type of regulation being examined. In addition, the HSP-NEO gene can be used to select G418-resistant cell lines. Compared with a frequently used selection vector, pSV2NEO, a construct containing the HSP-NEO gene is equally effective in producing G418-resistant colonies (data not shown). The covalent linkage of the HSP-NEO gene to the HSP-CAT gene ensures a 100% cotransfection frequency whether the HSP-NEO gene is being used as an internal control or as a selectable marker. Figure 2C contains the relevant sequences of the ID and each LS mutation presented for comparison with the wild-type sequences. The same LS mutations were used to generate the LSN and LSPN series. which differ only in the extent of wild-type upstream promoter sequences (-188 and -100, respectively).
A 5' deletion analysis of the human HSP70 promoter reveals the minimal sequences required for basal expression and Ela transactivation. To determine the minimal sequences required for basal expression and Ela transactivation, the expression of the ASN mutations was examined in the presence and absence of Ela (Fig. 3) promoter in Fig. 1 reveals which potentially functional upstream elements remain in a given deletion. Exact endpoints for the more closely spaced deletion mutations in the proximal sequences are indicated above the wild-type sequences in Fig. 2C . Ela was supplied by cotransfection of the plasmid pJOLC3 (Fig. 3 . lanes +). In transfections without Ela (lanes -). pJOLC3 was replaced by pAT153, a pBR322 derivative. Cytoplasmic RNA was isolated at 48 h after transfection and analyzed by RNase protection by using a CAT riboprobe (Fig. 3A) . Correctly initiated transcripts. marked by an asterisk in Fig. 3A . protected 400 nt of the probe. Wild-type basal levels were observed in the ASN -158. -105. and -74 deletion mutations. Loss of the CCAAT element in the -63 deletion mutation resulted in severely reduced basal levels. Similarly, an analysis of the 5' deletion series in the presence of Ela revealed that sequences to -74 were required for wild-type Ela-induced levels. A low level of Ela-induced activity was detected in a deletion mutation which extends to -63. Similar levels were observed in each remaining deletion construct except for the deletions which extend to -26 and -15. from which no transcripts were detected. Transcripts which randomly initiated upstream in the vector were also detected with the CAT riboprobe. These readthrough transcripts appear to be Ela inducible. Included in each transfection experiment was a positive control. E3-CAT, containing the Ela-responsive adenovirus E3 early gene promoter fused to the CAT gene. Uninduced levels and induction ratios of the 250-nt E3-CAT protection were similar throughout the deletion series, providing a control for both transfection efficiency and Ela inducibility.
From these data, we conclude that sequences within 74 bp of the start of transcriptional initiation are required for both proper basal expression and full Ela responsiveness. Therefore. we define the sequences to -74 as those which participate in the basal transcriptional complex and propose that some feature of this complex is the target for Ela. These results are consistent with previous studies (47) of the basal transcriptional elements of the human HSP70 promoter.
On the basis of the data in Fig. 3A , we would expect that the HSP-NEO gene regulated by 74 bp of the human HSP70 promoter would also be Ela responsive. To examine the levels of HSP-NEO transcripts, a separate hybridization was performed by using a NEO riboprobe. the protection of which generates a 220-nt fragment. Because of the covalent linkage to the HSP-CAT gene, the HSP-NEO gene is more informative as a positive control than the E3-CAT gene. Figure 3B shows that the NEO gene remained Ela responsive in each transfection experiment of the HSP-CAT deletion series. Thus, it appears that the approximately 10-fold reduction in the basal and Ela-induced levels of the A5N -63, -56, -54, -47, -42. -35, -26, and -15 constructs is due to deletion of transcription elements in the HSP70 promoter and not due to poor transfection efficiency, inability of the transfected DNA to support transcription. or lack of an Ela response.
LS mutations characterize the role of upstream elements in basal activity and the Ela response. The LSP series contains LS mutations in the context of a -100-bp HSP70 promoter (Fig. 2C) . The effects of mutations in specific upstream elements in the basal transcriptional complex were examined by cotransfection in the presence and absence of Ela (Fig.  4) . For valid quantification of the data, each transfection experiment included an internal reference that was equivalently expressed regardless of the promoter construct being tested or the induction conditions being used. Normalization of the HSP-CAT test signal to this internal control provided an accurate determination of the effect of each mutation by correcting for any technical variations. When the transfection conditions described in Materials and Methods were used, the RSV-CAT construct, containing the CAT gene controlled by the Rous sarcoma virus long terminal repeat. appeared to be nonresponsive to Ela and therefore served as the negative internal control. All of the HSP-CAT levels presented in Fig. 4A have been normalized to RSV-CAT levels as described in the legend to Fig. 4 , and the relative transcription levels are listed in Table 1 .
The data in Fig. 4A indicate that basal levels were reduced 11-fold in a CCAAT box mutation (-69/-55), 3.1-fold in a purine box mutation (-59/-49), 1.9-fold in a GC box mutation (-44/-35). and 5.2-fold in a -40/-26 LS mutation. The effect on basal activity in the LSPN -40/-26 mutation may be due to alteration of more than one transcription element. This mutation abolishes the binding site for an ATF/AP1-like factor (G. Williams, unpublished observations) and alters the first two bases of the TATA motif. We suggest that the effects of this mutation are due to alterations at an ATF/ API-like element at -37 because LSPN -40/-26 did not display the multiple transcription initiation site phenotype characteristic of TATA mutations (see LSN -32/-21 below). The threefold reduction in basal activity in the purine box mutation (-59/-49) may be due to its proximity to the CCAAT box since no effect on basal activity was detected in a different purine box mutation (-57/-47) which is located farther away from the CCAAT box.
The effects of Ela on the LSPN constructs are indicated in Fig. 4A and B. . In some lanes, there are two major readthrough protections. The lower one is generated because of the differences between the wild-type probe sequences and the corresponding transfected sequences that contain a Bglll linker. When the incongruity is not recognized by the RNase, the upper band is generated because of the differences between the probe and the LSPN construct in the sequences beyond -100. The gel was quantified by using densitometry, and the relative transcription levels are presented in Table 1 approximately equal for each construct. If competition for limiting regulatory proteins between the two promoters on the transfection vector were a factor, then we would expect these levels to vary. For example, mutation of a binding site for a regulatory protein at the HSP-CAT promoter would prevent binding there and allow an additional regulatory interaction at the HSP-NEO promoter. Other experiments examining stress regulation by using this transfection vector provide no evidence for any enhancer-type effects between the two promoters (Williams and Morimoto, in preparation). These data strongly suggest that the HSP-NEO gene acts Figure 3. mutations are induced to a greater degree in the -188 background than in the -100 background. This increase may be another example of the compensatory effects of distal sequences.
Positional effects of distal promoter elements. To examine the contribution of distal elements more directly, we designed an ID mutation in which 45 bp of upstream promoter sequences from -188 to -143 containing a CCAAT box and a GC box were fused to a deletion mutation with a 5' boundary at -49. The resulting construct, IDN -143/-49, places the distal CCAAT box in a position relative to the TATA box identical to that found for the proximal CCAAT box in the wild-type promoter ( Fig. 2C and 6A ) To assess the effects of these distal sequences, the basal and Ela-induced levels of this ID were compared directly with those of LSN WT, containing wild-type promoter sequences to -188, and to those of a A5N/-54 deletion construct. The values for relative HSP-CAT transcription levels were calculated by using RSV-CAT transcript levels as described in the legend to Fig. 4 . From the data in Fig. 6 , it appears that fusion of these distal sequences converted a weak -49 promoter to one which displays near-wild-type basal and Ela-induced levels. Basal levels from the ID construct were 92% of the wild-type promoter levels and fivefold greater than the levels from the -54 deletion mutation. All three constructs were induced by Ela 2.4-to 3.4-fold. Thus, in the proper context. these 45 bp from -188 to -143 contain fully functional transcription elements, consistent with the distal CCAAT and GC boxes being classical upstream elements that modulate promoter activity in a distance-dependent manner. The purpose of the redundancy of these upstream Fig. 4 . Quantification was performed as described in the legend to Fig. 4 . and the relative levels of the HSP-CAT transcripts are given below each lane. The A5N/-54 RNA was obtained from an experiment separate from that shown in Fig. 3 ; E3-CAT was replaced by RSV-CAT as the internal control. mutational analyses (35, 49) have suggested that factors that interact with the TATA element are involved in Ela regulation. To examine the effects of a mutation in the TATA box, we generated an LS construct, LSN -32/-21, which completely abolishes this element in the HSP70 promoter. The basal and Ela-induced levels of this construct were examined by cotransfection assays similar to those used to examine the role of upstream elements. The data in Fig. 7 indicate that this mutation in the TATA box reduced the basal levels of correctly initiated transcripts 6.9-fold. Moreover, multiple transcription initiation sites were utilized, a phenotype that has been reported previously (12) for the HSP70 promoter and is common to other promoters in which TATA boxes have been mutated (4 (A) S1 analysis of HSP-CAT transcripts. Si protections with an end-labeled DNA fragment were performed exactly as described previously (44) with 10 ,ug of RNA. Protection of a correctly initiated transcript resulted in a 400-nt fragment. The Si protection method displayed the multiple initiation site phenotype of the TATA box mutation more clearly than the RNase protection method. 0 Protections of aberrantly initiated transcripts; 0, protections of readthrough transcripts. RNA from the same samples used for the Si protections was analyzed by RNase protection with the CAT riboprobe (B) or the NEO riboprobe (C) to determine the levels of RSV-CAT and HSP-NEO transcripts, respectively. ple and repetitive transcription elements. We utilized a TK construct that contained only the TATA element from the TK promoter. This construct, when transfected into HeLa cells, produced no detectable level of TK transcripts (data not shown), consistent with previous observations (25) .
Fusion of a fragment containing the 56 bp from -100 to -44 of the HSP70 promoter to the TK gene at -37 resulted in the chimeric construct designated HSP70ITK. In this chimeric promoter, the HSP70 CCAAT element is 38 bp from the TK TATA element, whereas in the wild-type HSP70 promoter, the distance between the corresponding elements is 34 bp (Fig. 8A) . The Ela responsiveness of HSP70ITK was assessed by AdS infection of pooled stable cell lines cotransfected with this gene and, as an internal control, a wild-type TK gene containing a 10-bp deletion in the 5' untranslated region (TK WT) (26) .
The data in Fig. 8B indicate that this 56-nt fragment of the HSP70 promoter conferred AdS-inducible expression on the TK TATA promoter construct. The HSP70ITK fusion construct was induced 17-fold by AdS infection at 12 h compared with the 2.7-fold increase in the TK WT construct, resulting in a 6.3-fold relative increase (Fig. 8B) . Moreover, the kinetics of expression of HSP70ITK paralleled that of the endogenous HSP70 message. Between 8 and 12 h postinfection, the HSP70/TK and endogenous HSP70 mRNA levels increased, while TK q, WT mRNA levels remained constant (Fig. 8C) . This result demonstrates that the fusion of this 56-nt region containing a CCAAT element at -67 and a purine-rich element centered at -54 was required to confer basal expression and HSP70-like Ela responsiveness to a heterologous TATA element and test gene.
Role of the CCAAT and purine-rich elements in Ela responsiveness of the HSP70ITK chimeric promoter. To further define the elements within this 56-nt fragment, the HSP701 TK promoter fusion was subjected to oligonucleotide-directed in vitro mutagenesis. A 2-bp change was made in the CCAAT element (CCAAT -> CCccT) (65/66 mutation), and a 3-bp change was made in the purine box at -54 (AGGGAAA --AGttcAA) (52/54 mutation). The Ela inducibility of these HSP-TK constructs was assayed in transient cotransfections in the presence and absence of a plasmid encoding Ela (Fig.  9, + and -, respectively) . In all transfection experiments, an HSP-CAT LS construct (LSPN -44/-35; Fig. 4A ) that displays a wild-type response to Ela transactivation was used as a positive control. Also included was either RSV-CAT or TK vp WT to serve as a Ela-nonresponsive control for transfection efficiency so that relative fold induction of each HSP-TK test construct could be determined. The promoter of the TK tp WT gene has been shown previously to be insensitive to Ela transactivation in transient cotransfection assays (43) .
The transient cotransfection data for the HSP-TK promoters are presented in Fig. 9 , and the relative transcription levels are listed in Table 2 . Two parallel experiments are shown which differ in the Ela-nonresponsive internal control used. Transcription levels from each construct were normalized to the corresponding Ela-nonresponsive control, either RSV-CAT or TK t, WT, as described in the legend to Fig. 9 . The results for the unmodified HSP70ITK promoter are shown in panel I of Fig. 9 . Relative to either the RSV-CAT internal control (panel IA) or the TK ip WT internal control (panel IB), the HSP70ITK promoter fusion was induced 2.7-to 3.4-fold by Ela. In each case, the positive internal control HSP-CAT was induced by Ela. Mutation of 2 bp in the CCAAT element (mutation 65/66) resulted in no detectable transcripts in either the absence or presence of Ela (Fig. 9, panel III) , through the levels of TK ti WT and HSP-CAT messages clearly indicated that the transfection and Ela transactivation worked efficiently. Therefore, for this construct, the effects of Ela are indeterminable.
The effects of a mutation in the purine box (52/54) are shown in panel II of Fig. 9 . With this mutation, we observed an elevated basal level (7-to 14-fold) of HSP-TK transcripts that was not induced further by Ela, relative to either RSV-CAT (panel IIA) or TK tj WT (panel IIB) ( Table 2 ). The effects of the 52/54 mutation showed quantitative differences specific to the internal control used but were qualitatively consistent with respect to their lack of an Ela response. In each case, the positive internal control HSP-CAT was induced, confirming that the lack of induction for the 52/54 mutation was not due to the absence of an Ela response.
These results demonstrate that in the context of an HSP-TK promoter fusion, the CCAAT element is essential for detectable basal and Ela-induced expression. No other sequences in this promoter construct are present which can compensate for this mutation in the CCAAT element. Furthermore, a mutation in the purine box at 52/54 elevates basal transcription levels approximately 10-fold, and this construct appears to be nonresponsive to Ela transactivation. The diagrams at the top represent the array and relative spacing of promoter elements present in the HSP70ITK promoter fusion. The TK t WT gene, containing a 10-bp deletion in the 5' untranslated region, is also depicted. The sequence of the HSP70/ TK chimera is shown. The numbering of sequences from -100 to the fusion junction refers to the corresponding HSP70 promoter sequences. and the numbering from the fusion junction to the transcription initiation site refers to the corresponding TK promoter sequences. The CCAAT, purine-rich, and TATA elements are boxed, and the fusion junction is underlined. Lowercase letters refer to nucleotides which are wild type for neither HSP70 nor TK which result from fusion at linker sequences. (B) RNA analysis from Ad5-infected cell line. Cells from a pooled stable line containing the HSP70/TK and TK ti WT constructs were mock infected (lanes -) or AdS infected (lanes +) and harvested at the indicated times postinfection. Cytoplasmic RNA was analyzed by the RNase protection assay. The 420-nt protection corresponds to correctly initiated TK transcripts regulated by the chimeric promoter. The 384-nt fragment resulted from protection of the TK WT gene which diverges from the probe at +36. The endogenous HSP70 transcript was assayed by S1 nuclease analysis and generated a 150-nt protection. 0, Readthrough transcripts. (C) Quantification of RNA levels from AdS-infected cell line. The transcript levels for the HSP70ITK fusion in the AdS-infected (+) lanes at 4. 8. and 12 h are plotted with the corresponding TK tI WT transcript levels to compare the patterns of expression of these two constructs.
DISCUSSION
In this study, the transcription elements in the HSP70 promoter that regulate basal and Ela-induced expression were characterized by using two independent approaches. The results reveal the participation of several elements, some of which are repeated and functionally redundant. The relative contribution of each element is dependent upon both the nature of the element and its position in the promoter.
The first approach analyzed the effects of mutations in the context of an HSP70 promoter. A 5' deletion study defined a basal transcription unit containing the sequences to -74, extending previous studies from our laboratory (47) . Only those deletion mutations containing a complete basal transcription unit were capable of wild-type Ela-induced levels of expression. Therefore, some feature of the basal transcription unit or the complex associated with it is a target for Ela.
Several transcription elements involved in basal expression were identified by an analysis of LS mutations throughout the promoter region to -74. The phenotypes of LS mutations altering a CCAAT box at -67, a GC box at -48, and an ATF/AP1-like element at -37 reveal the participation of these upstream elements in basal expression. Furthermore, distal sequences between -100 and -188 can compensate weakly for mutations in the proximal CCAAT element. and when in the proper context, the sequences between -143 and -188 containing a CCAAT and GC element become a fully functional basal element. Thus, the distal CCAAT and GC elements may play a significant role in the compensatory distal promoter domain located between -84 and -1250 characterized previously (12) . In an independent HSP70 promoter analysis (12) , the effects on basal expression of mutations in the -67 CCAAT box and the -47 GC box were similar to those observed in our study. However, in the study by Greene et al. (12) , the phenotype that we describe for the -37 ATF/APl-like element was not observed, which may reflect the differences in the sequences or the severity of the mutations that were used in the two studies. mediated by a compact, multicomponent transcription complex that interacts with the promoter sequences to -74.
The ability of each HSP70 promoter mutation to respond to Ela was tested in cotransfection assays. Although absolute Ela-induced levels were affected in some cases, no mutation specifically abolished Ela inducibility. Any reduction in absolute Ela-induced levels was accompanied by a corresponding reduction in absolute basal levels, thereby maintaining a constant relative fold Ela induction. We conclude that Ela transactivation does not require any single basal transcription element.
The second approach analyzed specific HSP70 promoter elements out of their normal context by fusing them up- Morgan, unpublished observations) . These data are consistent with a model in which the purinerich element functions as a repressor binding site. In this model, the purine box mutation (52/54) prevents interaction with a repressor, allowing positive regulators to bind and resulting in elevated basal activity. Perhaps, in releasing the repressor, the 52/54 mutation simulates the effects of Ela. This mutation results in a promoter with a high level of expression, unable to be induced further by the activity of Ela. In the LS -57/-47 construct, interactions with factors at adjacent elements compensate for the mutation in vivo. Alternatively, the 52/54 mutation may have generated a new binding site for a positively acting factor or enhanced the interaction of a factor normally involved in basal regulation.
Three technical considerations have been central to our promoter analysis. First, we have analyzed all of our promoter constructs by the nuclease protection method. This method allowed us to distinguish between correctly initiated transcripts and readthrough transcripts. If the readthrough transcripts, which were also Ela induced, were translated into functional CAT proteins, then the results of a CAT enzyme assay (10) would be easily misinterpreted (for example, see LSPN -69/-55 data, Fig. 4A ). Second, we have chosen transfection conditions such that RSV-CA T and TK it WT appeared nonresponsive to Ela. These constructs provided a constant reference signal that was used for normalization. In experiments where the proportion of the Elaproducing plasmid in the transfection mix was increased, the reference construct was induced (data not shown) (34) . Therefore, because we have chosen conditions to allow for effective use of the internal reference, we are underestimating the effects of Ela. Third, Ela was supplied both by cotransfection and by AdS infection. The extent of induction was greater in Ad5 infections, presumably because of the difference in efficiency between the two techniques. The cotransfection technique was preferred because it avoids the complicating effects of viral infection on host cell RNA metabolism (5) .
Several laboratories have suggested that the factors which interact with the TATA box are the targets for Ela. In an LS analysis of the simple adenovirus Elb promoter, a TATA box mutation was reported that was characterized by reduced basal levels and loss of Ela inducibility (49) . These authors postulated the existence of a specific TATA binding factor that is responsive to Ela which interacts with the Elb promoter. Furthermore, they proposed that Ela transactivation of promoters with mutated TATA elements or of those which do not normally have a TATA element may depend on the activation of other transcription factors.
In a recent report by Simon et al. (35) . it was suggested that an Ela-regulated TATA factor interacts with the human HSP70 promoter. The results corresponding to their TATA box mutation (pHCpm6) and their CCAAT box mutations (pHCpml and pHCpm2) are inconsistent with those observed in our study and with those reported by others (12) . Although the upstream boundaries in their constructs are unclear, they reported no effect for a proximal CCAAT box mutation, whereas we and others (12. 28, 47) have demonstrated that mutations in this CCAAT box have a dramatic effect on expression. Their TATA box mutation, pHCpm6, had no detectable basal or heat shock-or Ela-induced levels. In contrast, using an analogous TATA box mutation. we observed reduced but readily detectable basal levels that were induced by both heat shock (G. Williams, manuscript in preparation) and Ela (Fig. 7) . In our study. we have shown that the HSP70/TK fusion construct containing the TK TATA element is Ela inducible despite the lack of sequence identity of the TK TATA box, TATTAA. with the proposed Ela-responsive TATA element consensus sequence (35) . Thus, our data are inconsistent with an HSP70-like TATA element requirement for Ela responsiveness. Furthermore. our results show that the specificity of Ela regulation observed for the HSP70 promoter is not mediated exclusively through a unique TATA element.
An alternative target for Ela regulation. one which may be common to all genes regulated by Ela, has been proposed in a recent study (7, 24 Mechanism of Ela induction. We have shown that Ela transactivates the human HSP70 promoter by interacting with the basal transcription complex. Every mutation which reduced basal levels affected Ela-induced levels similarly. Consistent with viral promoter studies and the inability to identify specific sequences required for Ela transactivation, the mechanism of Ela induction does not appear to involve direct DNA binding of Ela to a transcription element (8) or recruitment by Ela of cellular (or viral) factors that are normally not involved in basal regulation (16, 22, 30) .
What then is the target for Ela? To obtain a definitive answer to this question by using a transfection approach, the in vivo effect of a mutation on the DNA-protein interaction must be known. A mutation in the basal transcription unit, which alters a binding site for a transcription factor and results in a phenotype in vivo, may strictly prevent the interaction of that factor in vivo so that it is not present in the basal transcription complex. Alternatively, depending on the severity of a mutation, a change in an element in the basal transcription unit may result in a weak, unstable interaction aided by protein-protein interactions with other components in the transcription complex. An altered basal expression phenotype would be observed in vivo, but the corresponding transcription factor would still be present in the complex, albeit at lower levels. Thus, when considering the potential targets for Ela, one must remember that the actual in vivo effect of the mutation on protein-DNA interactions is unknown, thus revealing a major limitation of the transfection approach.
If a single basal factor were the sole target for Ela and mutation of its binding site resulted in complete loss of the factor from the complex, then the target for Ela would be identified by the non-Ela-responsive LSPN construct. However, if a single factor were the target and the mutation only weakened the interaction in the complex, then all of the LSPN constructs would be Ela inducible. If several of the basal factors were targets for Ela, then, once again, all of the LSPN constructs would be Ela inducible regardless of the in VOL. 9. 1989 vivo effect of the mutation on the corresponding protein-DNA interaction.
In (Fig. 8A ) but does not display HSP70-like Ela responsiveness. When the TK upstream elements were replaced with HSP70 promoter sequences, some aspect of the specificity of the HSP70 promoter was transferred. Some unique property of this HSP70 promoter fragment, either the order, the spacing, or the particular nucleotide sequence, is likely to be responsible for the observed Ela responsiveness. An understanding of this specificity will likely provide key insights into the mechanism of Ela transactivation and the general mode of transcriptional regulation by cellular transactivators.
